GTR 114693814
Tenders Are Invited For Pharmaceutical Products – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab Y Pazopanib
ICB — International Competitive Bid
Closes Jul 10, 2026
— 1 days left
Southern Europe
Tender Information
GTR Reference
114693814
Tendering Authority
Subscribe to view
Tender No
421284-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab Y Pazopanib
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Southern Europe
Political Region
European Union
Last Date of Bid Submission
10-07-2026
1 days left
Work Detail
Pharmaceutical Products – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab Y Pazopanib. Cs/Cc00/1101472323/26/Am: Framework Agreement For The Aggregate Supply Of Medicines Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab And Pazopanib For The Centers Of The Catalan Institute Of Health And Affiliated Centers: Hospital Del Mar De Barcelona, Sant Joan De Reus-Baix Camp, Hospital De Cerdanya - Aect European Grouping Of Territorial Cooperation, Institute Of Health Care And Service Management Sanitary
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
a8d35599-8021-4612-9c2a-b6253d50160e.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.